NCT03117361 2020-12-02Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and LenalidomidePharmaMarPhase 2 Terminated10 enrolled 37 charts
NCT00229203 2009-12-24A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple MyelomaPharmaMarPhase 2 Completed51 enrolled 10 charts